Two tobacco product manufacturers have been granted permission by the Irish High Court to challenge a new European Union directive that prohibits flavored heated tobacco products.
Ireland is set to adopt new European Union legislation by July 2024. However, the country's oldest tobacco manufacturer, PJ Carroll and Co., and next-generation nicotine company Nicoventures Trading, a subsidiary of BAT, argue that the EU directive is invalid. They are challenging both the Irish Minister for Health and Minister for Justice.
According to news reports from Ireland, previously, the heating and flavouring of tobacco products was not prohibited. However, the EU Commission has changed this rule and is hoping that member states will implement the ban by July 23rd.
In 2021, PJ Carroll, currently holding a 10% share in the electronic cigarette market in Ireland, announced that it is taking measures to commercialize heated tobacco products in Ireland, including flavored products.
However, PJ Carroll Company stated that the EU ban on these products severely limits their "ability to fully capitalize on a unique opportunity to become the first company in the Irish market to launch heated tobacco products for adult smokers, or else they will continue smoking.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
